AccuVein’s Leading Vein Visualization Technology at ONS Annual Congress

Share Article

Vein Access Critical for Oncology Patients

AccuVein Inc., the global leader in vein visualization and creator of the world’s only portable, non-contact vein illumination device, announced today that it will be showcasing the AccuVein AV400 device at the Oncology Nursing Society Annual Congress being held in San Antonio, Texas from April 28-May 1.

The AccuVein AV400 device provides a map of the patient’s vasculature on the skin’s surface to help facilitate access to veins for IV starts and blood draws. The AccuVein device has been shown to improve first stick success by a striking 350%, reduce pain by up to 59% and reduce procedure time by 78%.

“AccuVein’s leading vein visualization technology is improving patient care in thousands of facilities around the world,” said Heidi Siegel, AccuVein's Director of Marketing Communications. “Our participation in ONS will help us continue to make inroads in Oncology where venous access is particularly challenging and critically important.”  

AccuVein will be demonstrating their award winning vein illumination technology at booth #857. More information about AccuVein and a demonstration of the device in action can be found at

About AccuVein Inc.
AccuVein Inc. is the global leader in vein visualization technology. AccuVein’s flagship product, the AV400, is the world’s only hand-held, non-contact vein illumination solution. The device has won numerous awards including the prestigious Prism Award for Photonics Innovation. Healthcare professionals see a map of peripheral veins directly on the skin’s surface with the goal of accessing or avoiding veins. It is built on proprietary technology embodied in its growing patent portfolio on a broad range of imaging and medical diagnostic technologies. AccuVein is in use at more than 4,000 facilities and available for sale in over 120 countries worldwide. To see a demonstration of AccuVein in action, please visit

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Heidi Siegel
+1 631-367-0393 Ext: 106
Email >
Visit website